Prop 65 clone
This article was originally published in The Tan Sheet
Executive Summary
Connecticut measure resembling California's Proposition 65 would require warning labels on products that contain toxic substances; SB 1030 was subject to a Public Health Committee hearing March 15. Although bill exempts OTC drugs and dietary supplements, in a March 13 letter to co-sponsors Sen. Tony Nathaniel Harp and Rep. Mary Eberle, CHPA maintains "we are concerned that...once this precedent is set in Connecticut, it would be very easy to eliminate that protection in the future." CHPA and CTFA contend the bill would unduly worry consumers, place unnecessary relabeling costs on industry and needlessly mirror federal safeguards
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning